Skin Rash as Useful Marker of Erlotinib Efficacy in NSCLC and Its Impact on Clinical Practice

Neoplasma - Slovakia
doi 10.4149/neo_2013_004
Full Text
Abstract

Available in full text

Categories
Cancer Research
Date
Authors
Publisher

AEPress, s.r.o.

Related search

AB1474-HPR Are Clinical Pathways Useful in Clinical Practice?

2018English

The Efficacy of Erlotinib as Molecularly Targeted Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer (NSCLC): Case Reports in Western Iran

Journal of Solid Tumors
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2014English

Expression of Skin-Derived Antileukoproteinase (SKALP) in Reconstructed Human Epidermis and Its Value as a Marker for Skin Irritation

Acta Dermato-Venereologica
DermatologyMedicine
1998English

Is the Internet Useful for Clinical Practice?

Journal of the American Dental Association
MedicineDentistry
1999English

A Waxing and Waning Skin Rash

Gut
Gastroenterology
2004English

Acneiform Rash During Lung Cancer Therapy With Erlotinib (Tarceva®)

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2013English

Skin Rash From Dengue Fever

BMJ Case Reports
Medicine
2013English

P048 Clinical Efficacy of Osimertinib Mesylate Tablets in Treatment of Advanced NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Impact of Clinical Practice Guidelines on the Clinical Microbiology Laboratory

Journal of Clinical Microbiology
Microbiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy